Learn more
Log in
0 followers
Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.
Industries
Headquarters
Stage
Employees
Links
Robert Goodwin
6 members
3 members
Alnylam Pharmaceuticals
13 followers
Karyopharm Therapeutics
12 followers
NYU Langone Health
10 followers
Varsity Healthcare Partners
1 follower
Parexel
3 followers
Discover companies